BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24980133)

  • 1. β2-microglobulin, cystatin C, and creatinine and risk of symptomatic peripheral artery disease.
    Joosten MM; Pai JK; Bertoia ML; Gansevoort RT; Bakker SJ; Cooke JP; Rimm EB; Mukamal KJ
    J Am Heart Assoc; 2014 Jun; 3(4):. PubMed ID: 24980133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney function, bone-mineral metabolism markers, and future risk of peripheral artery disease.
    Yang C; Kwak L; Ballew SH; Garimella PS; Jaar BG; Folsom AR; Heiss G; Selvin E; Lutsey PL; Coresh J; Matsushita K
    Atherosclerosis; 2017 Dec; 267():167-174. PubMed ID: 28992939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preprocedure and Postprocedure Predictive Values of Serum β2-Microglobulin for Contrast-Induced Nephropathy in Patients Undergoing Coronary Computed Tomography Angiography: A Comparison With Creatinine-Based Parameters and Cystatin C.
    Li S; Zheng Z; Tang X; Peng L; Luo Y; Dong R; Zhao Y; Liu J
    J Comput Assist Tomogr; 2015; 39(6):969-74. PubMed ID: 26248154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change in Multiple Filtration Markers and Subsequent Risk of Cardiovascular Disease and Mortality.
    Rebholz CM; Grams ME; Matsushita K; Inker LA; Foster MC; Levey AS; Selvin E; Coresh J
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):941-8. PubMed ID: 25825481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels of β2-microglobulin and cystatin C are associated with left atrial size: additional link between the kidney and the heart.
    Liu YS; Wang X; Jiang WD; Huang ZW; Wang YM; Hao L; Xing JL; Wang L; Liu XX; Lounsbury P; Zhang M; Lu QH
    Clin Nephrol; 2013 Sep; 80(3):168-76. PubMed ID: 23849305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copeptin, B-type natriuretic peptide and cystatin C are associated with incident symptomatic PAD.
    Fatemi S; Acosta S; Gottsäter A; Melander O; Engström G; Dakhel A; Zarrouk M
    Biomarkers; 2019 Sep; 24(6):615-621. PubMed ID: 31215249
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of serum concentrations of β-trace protein, β2-microglobulin, cystatin C, and creatinine in the US population.
    Juraschek SP; Coresh J; Inker LA; Levey AS; Köttgen A; Foster MC; Astor BC; Eckfeldt JH; Selvin E
    Clin J Am Soc Nephrol; 2013 Apr; 8(4):584-92. PubMed ID: 23335043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Levels of Middle Molecules to Estimate Residual Kidney Function in Haemodialysis without Urine Collection.
    Vilar E; Boltiador C; Wong J; Viljoen A; Machado A; Uthayakumar A; Farrington K
    PLoS One; 2015; 10(12):e0143813. PubMed ID: 26629900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining Cystatin C and Creatinine Yields a Reliable Glomerular Filtration Rate Estimation in Older Adults in Contrast to β-Trace Protein and β2-Microglobulin.
    Werner K; Pihlsgård M; Elmståhl S; Legrand H; Nyman U; Christensson A
    Nephron; 2017; 137(1):29-37. PubMed ID: 28407629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in serum β2-microglobulin, retinol-binding protein, and cystatin C and their value in identifying early renal dysfunction in patients with chronic hepatitis B undergoing tenofovir or entecavir monotherapy: a comparative analysis].
    He J; Ning HB; Zeng YL; Li W; Li K; Shang J
    Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):643-646. PubMed ID: 27788718
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic values of serum cystatin C and beta2 microglobulin, urinary beta2 microglobulin and N-acetyl-beta-D-glucosaminidase in early acute renal failure after liver transplantation.
    Hei ZQ; Li XY; Shen N; Pang HY; Zhou SL; Guan JQ
    Chin Med J (Engl); 2008 Jul; 121(14):1251-6. PubMed ID: 18713542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta2-microglobulin and cystatin C in type 2 diabetes: assessment of diabetic nephropathy.
    Aksun SA; Ozmen D; Ozmen B; Parildar Z; Mutaf I; Turgan N; Habif S; Kumanlioğluc K; Bayindir O
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):195-200. PubMed ID: 15127324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population.
    Astor BC; Shafi T; Hoogeveen RC; Matsushita K; Ballantyne CM; Inker LA; Coresh J
    Am J Kidney Dis; 2012 May; 59(5):653-62. PubMed ID: 22305758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Beta 2-Microglobulin, Cystatin C, and Lipocalin-2 as Renal Biomarkers for Patients with Fabry Disease.
    Braga MC; Fonseca FLA; Marins MM; Gomes CP; Bacci MR; Martins AM; D'Almeida V
    Nephron; 2019; 143(4):217-227. PubMed ID: 31216546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal serum α-1 microglobulin for renal function assessment: comparison with β2-microglobulin and cystatin C.
    Nguyen C; Dreux S; Heidet L; Czerkiewicz I; Salomon LJ; Guimiot F; Schmitz T; Tsatsaris V; Boulot P; Rousseau T; Muller F
    Prenat Diagn; 2013 Aug; 33(8):775-81. PubMed ID: 23592560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in glomerular pore size is not restricted to pregnant women. Evidence for a new syndrome: 'Shrunken pore syndrome'.
    Grubb A; Lindström V; Jonsson M; Bäck SE; Åhlund T; Rippe B; Christensson A
    Scand J Clin Lab Invest; 2015 Jul; 75(4):333-40. PubMed ID: 25919022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney function estimated from serum creatinine and cystatin C and peripheral arterial disease in NHANES 1999-2002.
    Selvin E; Köttgen A; Coresh J
    Eur Heart J; 2009 Aug; 30(15):1918-25. PubMed ID: 19487236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystatin C and beta2-microglobulin: markers of glomerular filtration in critically ill children.
    Herrero-Morín JD; Málaga S; Fernández N; Rey C; Diéguez MA; Solís G; Concha A; Medina A
    Crit Care; 2007; 11(3):R59. PubMed ID: 17519026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change in novel filtration markers and risk of ESRD.
    Rebholz CM; Grams ME; Matsushita K; Selvin E; Coresh J
    Am J Kidney Dis; 2015 Jul; 66(1):47-54. PubMed ID: 25542414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum cystatin C level is an independent predictor of contrast-induced nephropathy and adverse outcomes in patients with peripheral artery disease undergoing endovascular therapy.
    Kim GS; Ko YG; Shin DH; Kim JS; Kim BK; Choi D; Hong MK; Jang Y
    J Vasc Surg; 2015 May; 61(5):1223-30. PubMed ID: 25595408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.